Haptena Therapeutics is a biotechnology company developing innovative approaches for genetically defined cancers.
Haptena Therapeutics has raised $3.5M in total funding. The most recent round was Seed. The last funding was announced in December 2025.
Haptena Therapeutics's investors include Claris Ventures.
Haptena Therapeutics is headquartered in Turin, Italy.
Haptena Therapeutics is a biotechnology company developing innovative approaches for genetically defined cancers.
Haptena Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Haptena Therapeutics — Funding & Investors." VCBacked, December 16, 2025, https://www.vcbacked.co/company/haptena-therapeutics. Accessed September 5, 2026.
VCBacked. (2025). Haptena Therapeutics — Funding & Investors. Retrieved September 5, 2026, from https://www.vcbacked.co/company/haptena-therapeutics
{{cite web |title=Haptena Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/haptena-therapeutics |website=VCBacked |access-date=September 5, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated